» Articles » PMID: 20195541

Helper T Cell Epitope-mapping Reveals MHC-peptide Binding Affinities That Correlate with T Helper Cell Responses to Pneumococcal Surface Protein A

Overview
Journal PLoS One
Date 2010 Mar 3
PMID 20195541
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the requirements for protection against pneumococcal carriage and pneumonia will greatly benefit efforts in controlling these diseases. Several proteins and polysaccharide capsule have recently been implicated in the virulence of and protective immunity against Streptococcus pneumonia. Pneumococcal surface protein A (PspA) is highly conserved among S. pneumonia strains, inhibits complement activation, binds lactoferrin, elicits protective systemic immunity against pneumococcal infection, and is necessary for full pneumococcal virulence. Identification of PspA peptides that optimally bind human leukocyte antigen (HLA) would greatly contribute to global vaccine efforts, but this is hindered by the multitude of HLA polymorphisms. Here, we have used an experimental data set of 54 PspA peptides and in silico methods to predict peptide binding to HLA and murine major histocompatibility complex (MHC) class II. We also characterized spleen- and cervical lymph node (CLN)-derived helper T lymphocyte (HTL) cytokine responses to these peptides after S. pneumonia strain EF3030-challenge in mice. Individual, yet overlapping peptides, 15 amino acids in length revealed residues 199 to 246 of PspA (PspA(199-246)) consistently caused the greatest IFN-gamma, IL-2, IL-5 and proliferation as well as moderate IL-10 and IL-4 responses by ex vivo stimulated splenic and CLN CD4(+) T cells isolated from S. pneumonia strain EF3030-challeged F(1) (B6xBALB/c) mice. IEDB, RANKPEP, SVMHC, MHCPred, and SYFPEITHI in silico analysis tools revealed peptides in PspA(199-246) also interact with a broad range of HLA-DR, -DQ, and -DP allelles. These data suggest that predicted MHC class II-peptide binding affinities do not always correlate with T helper (Th) cytokine or proliferative responses to PspA peptides, but when used together with in vivo validation can be a useful tool to choose candidate pneumococcal HTL epitopes.

Citing Articles

A new candidate epitope-based vaccine against PspA PhtD of : a computational experimental approach.

Shafaghi M, Bahadori Z, Barzi S, Afshari E, Madanchi H, Mousavi S Front Cell Infect Microbiol. 2023; 13:1271143.

PMID: 38035337 PMC: 10684780. DOI: 10.3389/fcimb.2023.1271143.


Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains.

Shafaghi M, Bahadori Z, Madanchi H, Ranjbar M, Shabani A, Mousavi S BMC Bioinformatics. 2023; 24(1):67.

PMID: 36829109 PMC: 9951839. DOI: 10.1186/s12859-023-05175-6.


In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A.

Afshari E, Cohan R, Sotoodehnejadnematalahi F, Mousavi S J Transl Med. 2023; 21(1):13.

PMID: 36627666 PMC: 9830136. DOI: 10.1186/s12967-022-03864-z.


Th17-Mediated Cross Protection against Pneumococcal Carriage by Vaccination with a Variable Antigen.

Kuipers K, Jong W, van der Gaast-de Jongh C, Houben D, van Opzeeland F, Simonetti E Infect Immun. 2017; 85(10).

PMID: 28717032 PMC: 5607416. DOI: 10.1128/IAI.00281-17.


Immunoinformatics Approach in Designing Epitope-based Vaccine Against Meningitis-inducing Bacteria (, , and Type b).

Zahroh H, Marup A, Tambunan U, Parikesit A Drug Target Insights. 2016; 10:19-29.

PMID: 27812281 PMC: 5091093. DOI: 10.4137/DTI.S38458.


References
1.
Altschul S, Madden T, Schaffer A, Zhang J, Zhang Z, Miller W . Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997; 25(17):3389-402. PMC: 146917. DOI: 10.1093/nar/25.17.3389. View

2.
Yu J, Goluguri T, Guentzel M, Chambers J, Murthy A, Klose K . Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice. Clin Vaccine Immunol. 2009; 17(2):215-22. PMC: 2815527. DOI: 10.1128/CVI.00361-09. View

3.
Rosloniec E, Brand D, Myers L, Esaki Y, Whittington K, Zaller D . Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol. 1998; 160(6):2573-8. View

4.
Castellino F, Zappacosta F, Coligan J, Germain R . Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J Immunol. 1998; 161(8):4048-57. View

5.
Manoury B, Hewitt E, Morrice N, Dando P, Barrett A, Watts C . An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature. 1999; 396(6712):695-9. DOI: 10.1038/25379. View